{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:11:30Z","timestamp":1791216690697,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Provincial Natural Science Foundation of Shandong province, China.","award":["ZR2020QH019"],"award-info":[{"award-number":["ZR2020QH019"]}]},{"name":"Provincial Natural Science Foundation of Shandong province, China.","award":["ZR2021MH066"],"award-info":[{"award-number":["ZR2021MH066"]}]},{"name":"Clinical Medicine Science and Technology Innovation Plan of Jinan City","award":["2024"],"award-info":[{"award-number":["2024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84092-x","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T09:47:26Z","timestamp":1736156846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["ApoB\/ApoA-\u0399 is associated with major cardiovascular events and readmission risk of patients after percutaneous coronary intervention in one year"],"prefix":"10.1038","volume":"15","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"84092_CR1","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1556\/650.2019.31301","volume":"160","author":"D Gheorghita","year":"2019","unstructured":"Gheorghita, D., Eordegh, G., Nagy, F. & Antal, M. Periodontal disease, a risk factor for atherosclerotic cardiovascular disease. Orv. Hetil. 160, 419\u2013425. https:\/\/doi.org\/10.1556\/650.2019.31301 (2019).","journal-title":"Orv. Hetil."},{"key":"84092_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1210\/er.2018-00184","volume":"40","author":"PB Sandesara","year":"2019","unstructured":"Sandesara, P. B., Virani, S. S., Fazio, S. & Shapiro, M. D. The forgotten lipids: Triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk. Endocr. Rev. 40, 537\u2013557. https:\/\/doi.org\/10.1210\/er.2018-00184 (2019).","journal-title":"Endocr. Rev."},{"key":"84092_CR3","first-page":"165","volume":"15","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Liu, M., Ferdous, M., Zhao, P. & Li, X. Serum lipoprotein(a) predicts 1-year major cardiovascular events in patients after percutaneous coronary intervention. Am. J. Transl. Res. 15, 165\u2013174 (2023).","journal-title":"Am. J. Transl. Res."},{"key":"84092_CR4","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/heartjnl-2019-315707","volume":"106","author":"SP Hoole","year":"2020","unstructured":"Hoole, S. P. & Bambrough, P. Recent advances in percutaneous coronary intervention. Heart 106, 1380\u20131386. https:\/\/doi.org\/10.1136\/heartjnl-2019-315707 (2020).","journal-title":"Heart"},{"key":"84092_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","volume":"73","author":"T Doenst","year":"2019","unstructured":"Doenst, T. et al. PCI and CABG for treating stable coronary artery disease: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 964\u2013976. https:\/\/doi.org\/10.1016\/j.jacc.2018.11.053 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"84092_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1272\/jnms.JNMS.2021_88-601","volume":"88","author":"S Tara","year":"2021","unstructured":"Tara, S. et al. Clinical characteristics, achievement of secondary prevention goals, and outcomes of patients with recurrent acute coronary syndrome. J. Nippon Med. Sch. 88, 432\u2013440. https:\/\/doi.org\/10.1272\/jnms.JNMS.2021_88-601 (2021).","journal-title":"J. Nippon Med. Sch."},{"key":"84092_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2147\/VHRM.S298436","volume":"17","author":"O Yagel","year":"2021","unstructured":"Yagel, O. et al. Long-term prognosis in young patients with acute coronary syndrome treated with percutaneous coronary intervention. Vasc. Health Risk Manag. 17, 153\u2013159. https:\/\/doi.org\/10.2147\/VHRM.S298436 (2021).","journal-title":"Vasc. Health Risk Manag."},{"key":"84092_CR8","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.3390\/jcm9103242","volume":"9","author":"S Biswas","year":"2020","unstructured":"Biswas, S. et al. Incidence and predictors of unplanned hospital readmission after percutaneous coronary intervention. J. Clin. Med. 9, 3242. https:\/\/doi.org\/10.3390\/jcm9103242 (2020).","journal-title":"J. Clin. Med."},{"key":"84092_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1136\/heartjnl-2019-316103","volume":"106","author":"Y Qin","year":"2020","unstructured":"Qin, Y. et al. Association between age and readmission after percutaneous coronary intervention for acute myocardial infarction. Heart 106, 1595\u20131603. https:\/\/doi.org\/10.1136\/heartjnl-2019-316103 (2020).","journal-title":"Heart"},{"key":"84092_CR10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.amjmed.2019.07.003","volume":"133","author":"JS Rana","year":"2020","unstructured":"Rana, J. S. et al. Risk of cardiovascular events in patients with type 2 diabetes and metabolic dyslipidemia without prevalent atherosclerotic cardiovascular disease. Am. J. Med. 133, 200\u2013206. https:\/\/doi.org\/10.1016\/j.amjmed.2019.07.003 (2020).","journal-title":"Am. J. Med."},{"key":"84092_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/joim.12381","volume":"278","author":"D Erlinge","year":"2015","unstructured":"Erlinge, D. Near-infrared spectroscopy for intracoronary detection of lipid-rich plaques to understand atherosclerotic plaque biology in man and guide clinical therapy. J. Intern. Med. 278, 110\u2013125. https:\/\/doi.org\/10.1111\/joim.12381 (2015).","journal-title":"J. Intern. Med."},{"key":"84092_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1093\/clinchem\/hvab140","volume":"67","author":"AD Sniderman","year":"2021","unstructured":"Sniderman, A. D. ApoB vs non-HDL-C vs LDL-C as markers of cardiovascular disease. Clin. Chem. 67, 1440\u20131442. https:\/\/doi.org\/10.1093\/clinchem\/hvab140 (2021).","journal-title":"Clin. Chem."},{"key":"84092_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/prot.26217","volume":"90","author":"RA Gisonno","year":"2022","unstructured":"Gisonno, R. A. et al. Evolutionary and structural constraints influencing apolipoprotein A-I amyloid behavior. Proteins 90, 258\u2013269. https:\/\/doi.org\/10.1002\/prot.26217 (2022).","journal-title":"Proteins"},{"key":"84092_CR14","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/diagnostics10080510","volume":"10","author":"A Nurtazina","year":"2020","unstructured":"Nurtazina, A., Kozhakhmetova, D., Dautov, D., Shakhanova, A. & Chattu, V. K. Apolipoprotein B\/A1 ratio as a diagnostic alternative to triglycerides and HDL-cholesterol for the prediction of metabolic syndrome among hypertensives in Kazakhstan. Diagnostics (Basel) 10, 510. https:\/\/doi.org\/10.3390\/diagnostics10080510 (2020).","journal-title":"Diagnostics (Basel)"},{"key":"84092_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00392-018-1381-5","volume":"108","author":"MC Bodde","year":"2019","unstructured":"Bodde, M. C. et al. Apolipoproteins A1, B, and apoB\/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up. Clin. Res. Cardiol. 108, 520\u2013538. https:\/\/doi.org\/10.1007\/s00392-018-1381-5 (2019).","journal-title":"Clin. Res. Cardiol."},{"key":"84092_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-019-1144-y","volume":"18","author":"M Tian","year":"2019","unstructured":"Tian, M. et al. Comparison of Apolipoprotein B\/A1 ratio, Framingham risk score and TC\/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention. Lipids Health Dis. 18, 202. https:\/\/doi.org\/10.1186\/s12944-019-1144-y (2019).","journal-title":"Lipids Health Dis."},{"key":"84092_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/met.2018.0067","volume":"17","author":"TT Wu","year":"2019","unstructured":"Wu, T. T. et al. Age, sex, and cardiovascular risk attributable to lipoprotein cholesterol among Chinese individuals with coronary artery disease: A case-control study. Metab. Syndr. Relat. Disord. 17, 223\u2013231. https:\/\/doi.org\/10.1089\/met.2018.0067 (2019).","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"84092_CR18","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1001\/jama.2018.2525","volume":"319","author":"EP Navarese","year":"2018","unstructured":"Navarese, E. P. et al. Association between baseline LDL-C level and total and cardiovascular mortality After LDL-C lowering: A systematic review and meta-analysis. JAMA 319, 1566\u20131579. https:\/\/doi.org\/10.1001\/jama.2018.2525 (2018).","journal-title":"JAMA"},{"key":"84092_CR19","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/MED.0000000000000596","volume":"28","author":"T Glavinovic","year":"2021","unstructured":"Glavinovic, T. & Sniderman, A. D. Apolipoprotein B: The rosetta stone of lipidology. Curr. Opin. Endocrinol. Diabetes Obes. 28, 90\u201396. https:\/\/doi.org\/10.1097\/MED.0000000000000596 (2021).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"84092_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach, F. et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 41, 111\u2013188. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455 (2020).","journal-title":"Eur. Heart J."},{"key":"84092_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/MBP.0000000000000549","volume":"26","author":"H Dong","year":"2021","unstructured":"Dong, H. et al. Associations of serum apolipoprotein A1, B levels and their ratio with blood pressure in Chinese adults with coronary artery disease. Blood Press. Monit. 26, 401\u2013406. https:\/\/doi.org\/10.1097\/MBP.0000000000000549 (2021).","journal-title":"Blood Press. Monit."},{"key":"84092_CR22","doi-asserted-by":"publisher","first-page":"8959019","DOI":"10.1155\/2021\/8959019","volume":"2021","author":"R Hua","year":"2021","unstructured":"Hua, R. et al. Apolipoprotein B\/A1 ratio is associated with severity of coronary artery stenosis in CAD patients but not in non-CAD patients undergoing percutaneous coronary intervention. Dis. Mark. 2021, 8959019. https:\/\/doi.org\/10.1155\/2021\/8959019 (2021).","journal-title":"Dis. Mark."},{"key":"84092_CR23","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s13300-020-00778-1","volume":"11","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Comparison of the efficacy and safety of rosuvastatin\/ezetimibe combination therapy and rosuvastatin monotherapy on lipoprotein in patients with type 2 diabetes: Multicenter randomized controlled study. Diabetes Ther. 11, 859\u2013871. https:\/\/doi.org\/10.1007\/s13300-020-00778-1 (2020).","journal-title":"Diabetes Ther."},{"key":"84092_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0140-6736(08)61076-4","volume":"372","author":"MJ McQueen","year":"2008","unstructured":"McQueen, M. J. et al. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case-control study. Lancet 372, 224\u2013233. https:\/\/doi.org\/10.1016\/S0140-6736(08)61076-4 (2008).","journal-title":"Lancet"},{"key":"84092_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(04)17019-0","volume":"364","author":"A Rosengren","year":"2004","unstructured":"Rosengren, A. et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 364, 953\u2013962. https:\/\/doi.org\/10.1016\/S0140-6736(04)17019-0 (2004).","journal-title":"Lancet"},{"key":"84092_CR26","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.925666","volume":"26","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. Effect of 2 different dosages of rosuvastatin on prognosis of acute myocardial infarction patients with new-onset atrial fibrillation in Jinan. China. Med Sci Monit 26, e925666. https:\/\/doi.org\/10.12659\/MSM.925666 (2020).","journal-title":"China. Med Sci Monit"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84092-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84092-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T10:10:01Z","timestamp":1736158201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84092-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84092"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84092-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"996"}}